How PBI/Gordon Companies leveraged our Sirolimus API Market report
VM Intelligence · Sample preview · Healthcare and Pharmaceuticals · Forecast 2027–2033
Urgent Care Market
- By Service Type: In-person Urgent Care, Teleurgent Care (Virtual Urgent Care), Mobile Urgent Care Services, Occupational Health Urgent Care
- By Patient Age Group: Pediatric Urgent Care, Adult Urgent Care, Geriatric Urgent Care
- By Ownership Model: Hospital-owned Urgent Care Centers, Physician-owned Urgent Care Centers, Retail Clinic-based Urgent Care, Independent Urgent Care Centers
- By Condition Treated: Minor Injuries and Fractures, Acute Illnesses (e.g., flu, infections), Diagnostic Services (e.g., X-ray, lab testing), Preventive Care and Vaccinations
- By Payer Type: Private Insurance, Medicare, Medicaid, Self-pay/Uninsured
Key Highlights
A snapshot of what the full report proves- 01 Market size - $X,XXX.XM global market in 2025 - the verified base-year revenue. Executive Summary →
- 02 Forecast - Full 2033 market projection modelled inside - unlock the forecast value to see where the market lands. Market Outlook →
- 03 Growth - Year-by-year CAGR across 2027–2033 - unlock the growth rate and the full model. Market Outlook →
- 04 Leading segment - In-person Urgent Care leads By Service Type at XX% share. Market, by Service Type →
- 05 Global coverage - Sized across 5 regions and 20 countries, each broken out by segment. Market, by Geography →
- 06 Competitive landscape - 15 companies profiled with SWOT, benchmarking and market-share analysis. Company Profiles →
Inside the Report
12 chapters · 291 pages- 01 Introduction Definition, segmentation & scope p.12 →
- 02 Research Methodology How the numbers were built p.20 →
- 03 Executive Summary The market in one chapter p.34 →
- 04 Market Outlook Drivers, restraints, trends p.66 →
- 11 Competitive Landscape 5 sections p.175 →
- 12 Company Profiles 15 players: SWOT & benchmarking p.183 →
Full report · locked preview
Everything inside the Urgent Care Market report
A complete, evidence-based study - 12 chapters and 122 sections covering market size, segmentation across 5 axes, regional analysis and 15 company profiles, forecast to 2033.
Segmentation covered
Service Type 4
Patient Age Group 3
Ownership Model 4
Condition Treated 4
Payer Type 4
Companies profiled
UnitedHealth Group (Optum)
CVS Health (MinuteClinic)
Concentra (a subsidiary of Select Medical)
MedExpress Urgent Care (a subsidiary of Optum)
NextCare Urgent Care
American Family Care (AFC)
FastMed Urgent Care
CityMD (a subsidiary of Summit Medical Group)
GoHealth Urgent Care
Urgent Care Associates of America (UCAOA)
Patient First
CareNow Urgent Care
+3 more
Verified · Analyst-reviewed · No payment to preview
Trusted & certified by
★★★★★ Excellent
★★★★★ Excellent
15 players profiled - tiered by revenue contribution, footprint and R&D capability.
ACE Matrix · p.153 →UnitedHealth Group (Optum)
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.155 →CVS Health (MinuteClinic)
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.160 →Concentra (a subsidiary of Select Medical)
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.166 →MedExpress Urgent Care (a subsidiary of Optum)
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.173 →NextCare Urgent Care
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.178 →American Family Care (AFC)
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.184 →FastMed Urgent Care
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.191 →CityMD (a subsidiary of Summit Medical Group)
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.196 →GoHealth Urgent Care
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.202 →Urgent Care Associates of America (UCAOA)
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.209 →Patient First
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.214 →CareNow Urgent Care
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.220 →ZoomCare
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.227 →Family First Urgent Care
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.232 →Premier Medical Group
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.238 →Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Global · 2025–2033
$10,856M by 2033 · 9.5% CAGR
Market estimates & forecast (USD Million)
Fig. 15 · p.34 →Segment mix, 2033 (% share)
Fig. 16 · p.35 →- In-person Urgent Care54.6
- Teleurgent Care (Virtual Urgent Care)12.2
- Mobile Urgent Care Services16.1
- Occupational Health Urgent Care17.2
Regions, 2025 → 2033 (USD Mn)
§6.1 · p.75 →North America$1,734M → $3,360M · 8.6%
Europe$1,209M → $2,716M · 10.6%
Asia Pacific$1,104M → $2,208M · 9.1%
Latin America$683.2M → $1,287M · 8.2%
Middle East and Africa$525.6M → $974.5M · 8.0%
Top countries, 2033 (USD Mn)
§6.2 · p.78 →Year-over-year growth (%)
§3.12 · p.44 →9.442026
9.462027
9.462028
9.472029
9.492030
9.512031
9.522032
9.532033
CAGR by region (%)
Fig. 22 · p.71 →Market share by company, 2033 (%)
Fig. 41 · p.152 →- UnitedHealth Group (Optum)15.0
- CVS Health (MinuteClinic)22.6
- Concentra (a subsidiary of Select Medical)10.4
- MedExpress Urgent Care (a subsidiary of Optum)9.2
- NextCare Urgent Care9.0
- American Family Care (AFC)5.8
- Others28.0
Segment contribution to growth (%)
Fig. 18 · p.39 →Service Type24.1%
Patient Age Group22.8%
Ownership Model22.6%
Condition Treated15.4%
Payer Type15.0%
Competitive positioning (ACE matrix)
Fig. 40 · p.153 →Adoption & penetration (% of addressable)
Fig. 12 · p.31 →Revenue by application (USD Mn)
§5.3 · p.62 →Demand by end-use (USD Mn)
§5.4 · p.66 →Average selling price trend (index, 2025=100)
Fig. 27 · p.58 →Top companies by revenue, 2033 (USD Mn)
Fig. 42 · p.155 →Revenue by region, 2033 (%)
Fig. 20 · p.70 →- North America31.9
- Europe25.8
- Asia Pacific20.9
- Latin America12.2
- Middle East and Africa9.2
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
8 players benchmarked across 6 dimensions — scored 0–100 from share, portfolio, reach, innovation, financials and installed base. Methodology · §8.1 · p.160 →
Competitive scorecard (score 0–100)
Table 31 · p.161 →| Company | Market share | Product portfolio | Geographic reach | Innovation & R&D | Financial strength | Customer base | Composite |
|---|---|---|---|---|---|---|---|
| UnitedHealth Group (Optum) | 95 | 93 | 90 | 97 | 97 | 97 | 95 |
| CVS Health (MinuteClinic) | 88 | 79 | 87 | 80 | 93 | 86 | 86 |
| Concentra (a subsidiary of Select Medical) | 75 | 70 | 68 | 68 | 71 | 65 | 70 |
| MedExpress Urgent Care (a subsidiary of Optum) | 78 | 66 | 74 | 74 | 74 | 76 | 74 |
| NextCare Urgent Care | 68 | 71 | 60 | 67 | 62 | 71 | 67 |
| American Family Care (AFC) | 59 | 58 | 57 | 47 | 68 | 67 | 59 |
| FastMed Urgent Care | 46 | 63 | 61 | 45 | 65 | 58 | 56 |
| CityMD (a subsidiary of Summit Medical Group) | 60 | 52 | 56 | 52 | 60 | 56 | 56 |
Vendor positioning (presence × innovation)
Fig. 43 · p.163 →Strengths profile (top 3 players)
Fig. 44 · p.165 →- UnitedHealth Group (Optum)
- CVS Health (MinuteClinic)
- Concentra (a subsidiary of Select Medical)
Capability coverage
§8.3 · p.168 →| Company | Global delivery | R&D depth | Digital platform | Sustainability | After-sales | Custom solutions |
|---|---|---|---|---|---|---|
| UnitedHealth Group (Optum) | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ |
| CVS Health (MinuteClinic) | ✓ | ✓ | ✓ | ◐ | ✓ | ◐ |
| Concentra (a subsidiary of Select Medical) | ◐ | ◐ | ◐ | ◐ | ◐ | − |
| MedExpress Urgent Care (a subsidiary of Optum) | ✓ | − | ✓ | ✓ | ◐ | ✓ |
| NextCare Urgent Care | ◐ | − | ◐ | ✓ | ✓ | ◐ |
| American Family Care (AFC) | ◐ | ◐ | − | ◐ | ◐ | − |
| FastMed Urgent Care | − | ◐ | − | − | − | − |
| CityMD (a subsidiary of Summit Medical Group) | ◐ | − | − | ◐ | ◐ | ◐ |
✓ Full ◐ Partial − Limited
Overall competitive index (composite, ranked)
Fig. 45 · p.170 →1UnitedHealth Group (Optum)95
2CVS Health (MinuteClinic)86
3MedExpress Urgent Care (a subsidiary of Optum)74
4Concentra (a subsidiary of Select Medical)70
5NextCare Urgent Care67
6American Family Care (AFC)59
7FastMed Urgent Care56
8CityMD (a subsidiary of Summit Medical Group)56
Competitive tiers
§8.4 · p.172 →Leader2
Set the pace on share, breadth and innovation.
UnitedHealth Group (Optum)CVS Health (MinuteClinic)
Challenger3
Strong scale, closing on the leaders.
Concentra (a subsidiary of Select Medical)MedExpress Urgent Care (a subsidiary of Optum)NextCare Urgent Care
Contender1
Focused players with pockets of strength.
American Family Care (AFC)
Niche2
Specialists in a single segment or region.
FastMed Urgent CareCityMD (a subsidiary of Summit Medical Group)
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Go-to-market strategy
Land Service Type in North America, then scale across Urgent Care Market — a $520M beachhead inside a $7.82B market.
Beachhead (SOM)$520Mobtainable near-term
Serviceable (SAM)$2.89Breachable market
Primary motionDirect + partner-ledgo-to-market
Time to scale5 Qto full motion
Ideal customer profile (who to sell to)
§GTM 1 · p.190 →Champion92 fit
In-person Urgent Care
Best fit — highest urgency & budget in Service Type.
Economic buyer79 fit
Teleurgent Care (Virtual Urgent Care)
Strong fit — clear ROI and a fast path to value.
End user68 fit
Mobile Urgent Care Services
Emerging fit — growing demand, longer sales cycle.
Market-entry sequence (beachhead → scale)
Fig. GTM 1 · p.192 →Beachhead · 2025–2026
Win Service Type in North America
Concentrated ICP, fastest proof and references.
Expand · 2026–2028
Add Patient Age Group & next regions
Repeat the motion in adjacent, look-alike segments.
Scale · 2028–2033
Full-market coverage + Ownership Model
Multi-channel, platform & ecosystem plays.
Channel mix (routes to market)
§GTM 3 · p.195 →Direct sales44%
Partner / channel28%
Digital / self-serve22%
Marketplaces6%
Positioning & messaging
§GTM 2 · p.194 →For Service Type leaders who need defensible market intelligence, VM Intelligence is the fastest, source-cited way to size, segment and win Urgent Care Market — unlike generic, static research.
Live & source-cited
Every figure triangulated from 600K+ sources and traceable.
Ready in minutes
A full, tailored report compiled on demand — not weeks.
Scope you control
Pick the chapters, regions and companies that matter.
GTM funnel & unit economics (conversion · CAC / LTV)
Fig. GTM 2 · p.198 →Awareness100%
Marketing qualified38%
Sales qualified20%
Evaluation15%
Closed-won7%
$13.4KCAC
$52KLTV
3.9:1LTV : CAC
< 2 moCAC payback
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Investment thesis
Urgent Care Market is a high-growth opportunity — $5.03B by 2033, compounding at 10.3%.
TAM · 2025$2.29Btoday
TAM · 2033$5.03Bforecast
CAGR10.3%2027–2033
Cumulative$31.6Brevenue opportunity
Market opportunity (TAM · SAM · SOM)
Fig. 3 · p.14 →TAM$5.03BTotal addressable market
SAM$1.83BServiceable available market
SOM$376MServiceable obtainable market
Growth trajectory (USD Million)
Fig. 4 · p.16 →Why invest now
§2.1 · p.10 →10.3% CAGR
Demand compounds through 2033, outpacing GDP across Service Type.
Global tailwinds
North America leads today; fastest gains coming from emerging regions.
Structural shift
Adoption in Service Type moving from early to mainstream — durable secular demand.
Consolidation upside
15+ players, no runaway leader — room to build scale and roll up share.
Investment highlights
§2.2 · p.12 →$5.03BLarge & growingTAM by 2033 at 10.3% CAGR
$1.83BServiceable nowreachable with today’s model
$376MBeachhead winobtainable near-term share
15+Fragmented fieldplayers — consolidation runway
Return scenarios (2033 market value)
Fig. 6 · p.22 →$3.93BBear6.7% CAGR
$5.03BBase10.3% CAGR
$6.44BBull13.7% CAGR
Key risks & mitigants
§9.1 · p.180 →- Input-cost volatilityLong-term supply contracts & hedging
- Regulatory / policy shiftsDiversified exposure across 5 regions
- Technology disruptionR&D pipeline & Patient Age Group optionality
- Customer concentrationBroaden installed base beyond top accounts
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Board pack · executive summary
Urgent Care Market — a $1.09B market by 2033. Plan: grow share from 7.9% to 13.0%.
Market size · 2033$1.09Btotal addressable
Market CAGR7.3%2027–2033
Target share13.0%from 7.9% today
Revenue ambition$142Mby 2033
Strategic scorecard (current vs 2033 target)
Table 1 · p.6 →| Objective | Current | Target · 2033 | Status |
|---|---|---|---|
| Market share | 7.9% | 13.0% | On track |
| Revenue | $90M | $142M | On track |
| Geographic coverage | 2 of 5 regions | 5 of 5 regions | At risk |
| Segment coverage | 3 of 5 axes | 5 of 5 axes | On track |
| Gross margin | 30.0% | 43.5% | Ahead |
| Customer retention | 84.9% | 96.2% | Behind |
Where to play (strategic priorities)
§1.2 · p.8 →1
Lead segment
Win in Service Type
Largest revenue pool and fastest secular demand — concentrate to build share here first.
2
Geographic
Expand across North America & beyond
Deepen the leading region, then scale into the fastest-growing emerging markets.
3
Adjacency
Build Patient Age Group capability
A defensible second engine — invest in Patient Age Group to widen the moat and cross-sell.
Strategic roadmap (2025–2033)
Fig. 1 · p.10 →Phase 1 · Foundation
2025–2027
- Secure core Service Type share
- Fix unit economics
- Stand up data & ops
Phase 2 · Scale
2028–2030
- Enter new regions
- Launch Patient Age Group
- Selective M&A
Phase 3 · Lead
2031–2033
- Category leadership
- Premium mix & margin
- Platform & ecosystem
Board decisions & asks
§1.4 · p.14 →- Approve $16M capacity & capability investment
- Greenlight bolt-on M&A in Patient Age Group
- Authorise North America expansion plan
- Fund R&D program for Service Type leadership
Risk watchlist (RAG)
§9 · p.180 →- Demand / macro slowdownAhead
- Competitive share lossAt risk
- Input-cost & supply riskAt risk
- Regulatory / policy changeOn track
- Execution & talentAhead
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Sales deck · value proposition
Win the Urgent Care Market conversation — a $7.19B market you can size, segment and defend in minutes.
Market size · 2033$7.19Btotal opportunity
Growth8.4%CAGR to 2033
Addressable buyers1,431+accounts in scope
Typical ROI6.1×in year one
Who buys (target personas)
§1.1 · p.4 →Product / BU leader
Head of Service Type
Goal Grow share in Service Type
Pain Blind spots on demand, pricing & competitors.
Regional GM
North America lead
Goal Prioritise the right markets
Pain No granular, country-level view of the market.
M&A / strategy
Strategy & Corp Dev
Goal Find where to invest or acquire
Pain Slow, inconsistent third-party research.
From pain to solution
§1.2 · p.6 →Decisions made on stale, generic dataLive, source-cited figures, continuously updated
Weeks waiting on a research vendorA full report compiled in minutes
No view of competitors or whitespaceCompany profiles, ACE matrix & benchmarking
Hard to defend the numbers internallyEvery figure traceable to its original source
The business case (ROI)
Fig. 2 · p.9 →6.1×return on cost, year one
< 4 mopayback period
$58K+research cost avoided
10×faster than a custom study
Time to insight
Cost to run
Risk of a wrong call
Why buyers trust it (proof points)
§1.3 · p.12 →600K+source studies indexed
100%analyst-reviewed
15+players profiled in this market
Coverage includes
UnitedHealth Group (Optum)CVS Health (MinuteClinic)Concentra (a subsidiary of Select Medical)MedExpress Urgent Care (a subsidiary of Optum)NextCare Urgent CareAmerican Family Care (AFC)FastMed Urgent CareCityMD (a subsidiary of Summit Medical Group)+7 more
Objection handling
§1.4 · p.14 →“We already have market data.”
This triangulates 600K+ sources into one current, defensible view — not another silo.
“How do we know it’s accurate?”
Analyst-reviewed, and every figure is source-cited and traceable to its origin.
“It’s not in the budget.”
A fraction of a single analyst-day — and it pays back on the first decision it informs.
“We need it tailored to us.”
Choose the chapters, regions and companies before you build — you only pay for scope.
What you get (packages)
§1.5 · p.16 →Report
- Full multi-chapter report
- Market size, share & forecast
- Segment & regional breakdowns
- PDF + editable Excel + PPT
Most popular
Report + Add-ons
- Everything in Report
- Interactive Visualizer
- Competitive benchmarking
- Investor / board / sales decks
Enterprise
- Multiple reports & markets
- Team seats & sharing
- Analyst support & custom scope
- API / data-feed options
Almost there
Access your Urgent Care Market report
Sign in to unlock the full report - it’s compiled live and ready in minutes.
or continue with your email
Your report is ready to access
Urgent Care Market Report is ready
Verify your email to unlock it. We sent a 6-digit code to your inbox.
That code is invalid or expired. Please try again.
Trusted by strategy, finance & consulting teams
Related Reports
Healthcare and Pharmaceuticals · scroll →Urgent Care Clinic Market
Market size, share, segmentation and regional forecast.
$3.3B market · 2025 base year
View reportUrgent Care Center Services Market
Market size, share, segmentation and regional forecast.
$786M market · 2025 base year
View reportUrgencies Stretcher Trolleys Market
Market size, share, segmentation and regional forecast.
$3.3B market · 2025 base year
View reportUrethroscope Market
Market size, share, segmentation and regional forecast.
$1.8B market · 2025 base year
View reportUrethral Stricture Treatment Device Market
Market size, share, segmentation and regional forecast.
$968M market · 2025 base year
View reportUrethral Slings Market
Market size, share, segmentation and regional forecast.
$5.3B market · 2025 base year
View reportUrethral Cancer Treatment Market
Market size, share, segmentation and regional forecast.
$6.2B market · 2025 base year
View reportUrethral Bulking System Market
Market size, share, segmentation and regional forecast.
$3.6B market · 2025 base year
View reportUrethral Bulking Agents Market
Market size, share, segmentation and regional forecast.
$4.9B market · 2025 base year
View reportUrethral Bougies Market
Market size, share, segmentation and regional forecast.
$376M market · 2025 base year
View reportUreterorenoscopy Market
Market size, share, segmentation and regional forecast.
$3.7B market · 2025 base year
View reportUreteral Vascular Access Device Market
Market size, share, segmentation and regional forecast.
$1.9B market · 2025 base year
View reportThe showdown
Custom-built vs. off-the-shelf
Scroll to watch them go head-to-head
WinnerVMR Custom Report
- Tailored to your exact scope
- Delivered in minutes
- Live, always-current data
- Fully editable data (XLSX)
- You choose the companies
- Source-cited & traceable
Off-the-shelf PDF
- Generic, one-size template
- Waits 2–5 days
- A fixed snapshot in time
- Locked, flat PDF
- Preset company list
- Opaque sourcing
Customer Testimonials
Proof from industry leaders who rely on us
These stories come from the executives who depend on VMR’s intelligence for market entry, expansion, assessment, and planning. Their outcomes and experiences reflect our commitment to clarity.
600,000+source studies indexed
100%analyst-reviewed
Every figuresource-cited & traceable
In their words
Watch clients tell their story
How VMR helped University of Limerick with Anesthesia Monitoring Devices
How VMR helps brands expand into Africa & emerging markets
Unlock your GTM strategy: an Elsewedy Electric success story
Beyond sales data: layering NielsenIQ data to support strategy
How VMR became the trusted partner for United Alloy
Questions, answered
How is the research actually conducted?
Every report is compiled from VMR’s continuously-updated intelligence across 600,000+ source studies - primary interviews, company filings, trade data, and government & industry databases. Figures are triangulated across multiple credible sources, then reviewed by a research analyst before your report is delivered.
What exactly do I get inside the report?
A full multi-chapter study: market definition & methodology, executive summary, market outlook (drivers, restraints, trends, Porter’s Five Forces), segment deep-dives, regional & country breakdowns, competitive landscape, and a full profile for every company you select - with interactive charts and data tables throughout.
How accurate are the numbers, and can I trust them?
Market sizing is reconciled across leading sources (Gartner, BCG, MarketsandMarkets, government bodies and more), with outliers removed and a confidence-graded median used for the base year. Every figure is source-cited and traceable to its origin, and an analyst validates the model before delivery.
Can I customise the chapters, regions and companies?
Yes. Choose exactly the chapters, regions and countries, and the companies you want benchmarked before you build - then adjust your selection and recompile anytime from your account. You only pay for the scope you need.
What formats do I receive, and is the data editable?
Every report is readable online in full. Downloadable formats are available as optional $99 add-ons: a formatted PDF and a fully editable XLSX containing all underlying data tables - so you can re-chart, re-model, or drop any figure straight into your own deck.